Company Applied Genetic Technologies Corporation
Equities
AGTC
US03820J1007
Biotechnology & Medical Research
Business Summary
Number of employees: 102
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Fellows
CEO | Chief Executive Officer | 67 | 22-10-31 |
David Jacobs
CTO | Chief Tech/Sci/R&D Officer | - | 22-06-07 |
Nadia Waheed
CTO | Chief Tech/Sci/R&D Officer | 47 | 22-11-30 |
Abraham Scaria
CTO | Chief Tech/Sci/R&D Officer | - | 21-11-14 |
Ashwin Datt
BRD | Director/Board Member | - | 22-11-30 |
Chris Hollowood
BRD | Director/Board Member | 50 | 22-11-30 |
Hope D'Oyley-Gay
LAW | General Counsel | - | 21-11-10 |
Gerald Reynolds
TRE | Treasurer | - | 20-02-29 |
Janet Rae
LAW | General Counsel | - | 21-06-17 |
Matthew Feinsod
PRN | Corporate Officer/Principal | - | 14-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Fellows
CEO | Chief Executive Officer | 67 | 22-10-31 |
Chris Hollowood
BRD | Director/Board Member | 50 | 22-11-30 |
Ashwin Datt
BRD | Director/Board Member | - | 22-11-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 67,686,195 | 67,316,723 ( 99.45 %) | 54,000 ( 0.0798 %) | 99.45 % |
Company contact information
Beacon Therapeutics (USA), Inc.
14193 NW 119th Terrace Suite 10
32615, Alachua
+386 462 2204
http://agtc.comSector
1st Jan change | Capi. | |
---|---|---|
-1.92% | 103B | |
+0.84% | 95.71B | |
+1.69% | 22.02B | |
-17.03% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-15.03% | 15.52B | |
+3.61% | 13.86B | |
+34.81% | 12.04B |